Skip to main content

Table 1 Demographic, anatomic and surgical characteristics of patients stratified by composite outcome

From: Predictive value of Cardiac Magnetic Resonance: new and old parameters in the natural history of repaired Tetralogy of Fallot

Variable

No outcome (N = 42)

Outcome (N = 88)

All patients (N = 130)

p

Gender, male

16

(38.1%)

48

(54.5%)

64

(49.2%)

0.079

Body mass index (kg/m2)

21.8

(20.0 -24.4)

23.1

(21.1–25.2)

22.6

(20.7–25.0)

0.127

Body surface area (m2)

1.7

(1.5–1.9)

1.7

(1.6–1.8)

1.7

(1.6–1.8)

0.811

Weight (kg)

60.0

(53.0–75.0)

64.0

(55.5–71.5)

64.0

(55.0–73.0)

0.424

Height (m)

1.7

(1.6–1.7)

1.7

(1.6–1.7)

1.7

(1.6–1.7)

0.657

Age at first CMR (years)

18.5

(17.0 -20.9)

27.9

(19.2–43.0)

22.1

(18.0 -36.7)

< 0.001

Age at TOF repair (months), N = 127

12.6

(7.4–27.0)

30.1

(11.4–88.9)

23.1

(9.5–67.7)

0.001

Time from repair to CMR (years), N = 127

17.1

(16.2–19.1)

23.5

(17.4–33.2)

19.1

(16.8–28.5)

< 0.001

Follow-up time after first CMR (months)

85.2

(46.0 -125.6)

125.8

(81.3 -158.5)

110.4

(70.5 -149.4)

0.002

Time without arrhythmias (months), N = 116

65.5

(33.9–87.5)

64.0

(30.4 -118.6)

64.0

(32.3 -101.8)

0.816

Type of TOF repair

      

0.461

 Transannular patch

26

(61.9%)

54

(61.4%)

80

(61.5%)

 

 Infundibular patch

14

(33.3%)

21

(23.9%)

35

(26.9%)

 

 Double revision of repair

1

(2.4%)

5

(5.7%)

6

(4.6%)

 

 Other

0

(0.0%)

2

(2.3%)

2

(1.5%)

 

 Unknown

1

(2.4%)

6

(6.8%)

7

(5.4%)

 

Pulmonary valve reintervention

      

0.001

 No reintervention

31

(73.8%)

39

(44.3%)

70

(53.8%)

 

 Homograft

7

(16.7%)

45

(51.1%)

52

(40.0%)

 

 Valvuloplasty

1

(2.4%)

0

(0.0%)

1

(0.8%)

 

 PPVI

3

(7.1%)

4

(4.5%)

7

(5.4%)

 

PA procedures pre-CMR

      

0.108

 None

34

(81.0%)

79

(89.8%)

113

(86.9%)

 

 Monolateral PA stent(s)

6

(14.3%)

3

(3.4%)

9

(6.9%)

 

 Bilateral PA stents

1

(2.4%)

1

(1.1%)

2

(1.5%)

 

 PTA

1

(2.4%)

5

(5.7%)

6

(4.6%)

 

PA procedures post-CMR pre-homograft

      

0.552

 None

41

(97.6%)

81

(92.0%)

122

(93.8%)

 

 Monolateral PA stent(s)

1

(2.4%)

3

(3.4%)

4

(3.1%)

 

 Bilateral PA stents

0

(0.0%)

2

(2.3%)

2

(1.5%)

 

 PTA

0

(0.0%)

2

(2.3%)

2

(1.5%)

 

PA procedures post-homograft

      

0.616

 None

42

(100.0%)

86

(97.7%)

128

(98.5%)

 

 Homograft PTA

0

(0.0%)

1

(1.1%)

1

(0.8%)

 

 Homograft stent and PTA

0

(0.0%)

1

(1.1%)

1

(0.8%)

 
  1. CMR = cardiac magnetic resonance; TOF = Tetralogy of Fallot; PA = pulmonary artery (arteries); PPVI = percutaneous pulmonary valve implantation; PTA = percutaneous transluminal angioplasty